What Researchers Did
Researchers conducted an 18-month uncontrolled study to assess the effects of hyperbaric oxygen therapy in 97 individuals with multiple sclerosis.
What They Found
Among 97 multiple sclerosis patients, two-thirds with progressive disease and one-third with stable disease, bladder function tended to improve over 12 months of hyperbaric oxygen treatment. However, there was no evidence that the treatment led to an improvement in mobility or communication.
What This Means for Canadian Patients
Canadian patients with multiple sclerosis might experience some improvement in bladder function with hyperbaric oxygen therapy, based on these findings. However, they should not expect significant improvements in mobility or communication from this treatment.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
A significant limitation of this study is its uncontrolled design, which makes it difficult to definitively attribute observed improvements solely to the hyperbaric oxygen therapy.